Andere Sprachen Cochlear Limited

Aktien

898321

AU000000COH5

COH

Medizinische Versorgung

Markt geschlossen - Australian S.E. Andere Börsenplätze 06:11:53 23.01.2026			% 5 Tage	Veränd. 1. Jan.
273,73 ^AUD	-0,82 %		+1,94 %	+5,01 %

08.01.	Cochlear gibt Verfügbarkeit des Nucleus Nexa Systems für US-Militärveteranen bekannt	CI
11.12.	Planisware erweitert seine Präsenz im asiatisch-pazifischen Raum mit der Eröffnung eines Büros und zweier neuer Rechenzentren in Australien	CI

Andere Sprachen

08.01.	Cochlear Announces Availability of Nucleus Nexa System to Us Military Veterans
11.12.	Planisware : ouvre un bureau et de deux nouveaux data centers en Australie
11.12.	Planisware Expands Its Asia-Pacific Footprint with the Opening of an Office and Two New Data Centers in Australia
01.12.	Archer Materials Limited Announces Board Changes, Effective December 1, 2025
23.10.25	Cochlear Reaffirms Fiscal 2026 Underlying Profit Guidance
22.09.25	Cochlear Limited Announces Franked Ordinary Dividend for the Six Months Ended June 30, 2025, Payable on October 13, 2025
04.09.25	Banking, consumer sectors lift Australia shares after sell-off
18.08.25	Cochlear's Fiscal 2025 Revenue Weighed Down by Uncertainty of Implant Launch; Innovation Key to Boosting Market Share, Jarden Says
15.08.25	Australian Shares Rise; Cochlear Posts Higher Fiscal Year 2025 Underlying Earnings, Revenue
15.08.25	Cochlear : 2025 Annual / Sustainability Report
15.08.25	Cochlear : 2025 Tax Contribution Report
15.08.25	Cochlear Posts Higher Fiscal 2025 Underlying Earnings, Revenue
15.08.25	Cochlear Limited's Equity Buyback Plan Extended till August 28, 2026.
14.08.25	Cochlear Posts Fiscal 2025 Underlying EPS of AU$5.98, Total Revenue of AU$2.34 Billion
14.08.25	Cochlear approved buyback of up to A$75 mln in shares
14.08.25	Tranche Update on Cochlear Limited's Equity Buyback Plan announced on August 15, 2024.
14.08.25	Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2025, Payable on October 13, 2025
14.08.25	Cochlear Limited Reports Earnings Results for the Full Year Ended June 30, 2025
28.07.25	Cochlear Limited Announces Board Changes
08.07.25	Cochlear Limited Launches Smart Cochlear Implant System
08.07.25	Cochlear says co receives FDA approval for new Nucleus Nexa system
08.07.25	Cochlear Secures US FDA Approval for Smart Cochlear Implant System
12.06.25	Cochlear : Australia Nucleus Nexa Media Release
12.06.25	Cochlear : New Zealand Nucleus Nexa Media Release
12.06.25	Cochlear : AU & NZ Hearing Loss Fact Sheet

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Cochlear Limited

Aktien

898321

AU000000COH5

COH

Medizinische Versorgung

Andere Sprachen

Filter